Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 5
2004 6
2005 7
2006 3
2007 5
2008 3
2009 9
2010 2
2011 5
2012 14
2013 10
2014 10
2015 7
2016 16
2017 13
2018 13
2019 23
2020 24
2021 29
2022 37
2023 46
2024 27

Text availability

Article attribute

Article type

Publication date

Search Results

277 results

Results by year

Filters applied: . Clear all
Page 1
St. John's wort extract with a high hyperforin content does not induce P-glycoprotein activity at the human blood-brain barrier.
El Biali M, Wölfl-Duchek M, Jackwerth M, Mairinger S, Weber M, Bamminger K, Poschner S, Rausch I, Schindler N, Lozano IH, Jäger W, Nics L, Tournier N, Hacker M, Zeitlinger M, Bauer M, Langer O. El Biali M, et al. Among authors: zeitlinger m. Clin Transl Sci. 2024 May;17(5):e13804. doi: 10.1111/cts.13804. Clin Transl Sci. 2024. PMID: 38700454
Advancing 6-bromo-7-[11C]methylpurine to clinical use: improved regioselective radiosynthesis, non-clinical toxicity data and human dosimetry estimates.
Mairinger S, Jackwerth M, Soukup O, Blaickner M, Decristoforo C, Nics L, Pahnke J, Hacker M, Zeitlinger M, Langer O. Mairinger S, et al. Among authors: zeitlinger m. EJNMMI Radiopharm Chem. 2024 Apr 29;9(1):34. doi: 10.1186/s41181-024-00265-z. EJNMMI Radiopharm Chem. 2024. PMID: 38683266 Free PMC article.
A national evaluation analysis and expert interview study of real-world data sources for research and healthcare decision-making.
Mikl V, Baltic D, Czypionka T, Degelsegger-Márquez A, Forgó N, Gouya-Lechner G, Herzog A, Klimek P, Lumenta DB, Mraz B, Ostermann H, Scharinger R, Stamm T, Strassnig M, Zeitlinger M, Pleiner-Duxneuner J. Mikl V, et al. Among authors: zeitlinger m. Sci Rep. 2024 Apr 28;14(1):9751. doi: 10.1038/s41598-024-59475-9. Sci Rep. 2024. PMID: 38679653 Free PMC article.
First-in-human study of alpibectir (BVL-GSK098), a novel potent anti-TB drug.
Pieren M, Abáigar Gutiérrez-Solana A, Antonijoan Arbós RM, Boyle GW, Davila M, Davy M, Gitzinger M, Husband L, Martínez-Martínez MS, Mazarro DO, Pefani E, Penman SL, Remuiñán MJ, Vlasakakis G, Zeitlinger M, Dale GE. Pieren M, et al. Among authors: zeitlinger m. J Antimicrob Chemother. 2024 Apr 24:dkae107. doi: 10.1093/jac/dkae107. Online ahead of print. J Antimicrob Chemother. 2024. PMID: 38656557
Effects of Lung Inflammation and Injury on Pulmonary Tissue Penetration of Meropenem and Vancomycin in a Model of Unilateral Lung Injury.
Geilen J, Kainz M, Zapletal B, Schweiger T, Jäger W, Maier-Salamon A, Zeitlinger M, Stamm T, Ritschl V, Geleff S, Schultz MJ, Tschernko E. Geilen J, et al. Among authors: zeitlinger m. Int J Antimicrob Agents. 2024 Apr 20:107180. doi: 10.1016/j.ijantimicag.2024.107180. Online ahead of print. Int J Antimicrob Agents. 2024. PMID: 38649034 Free article.
Pharmacokinetics of isavuconazole at different target sites in healthy volunteers after single and multiple intravenous infusions.
Bergmann F, Wölfl-Duchek M, Jorda A, Al Jalali V, Leutzendorff A, Sanz-Codina M, Gompelmann D, Trimmel K, Weber M, Eberl S, Van Os W, Minichmayr IK, Reiter B, Stimpfl T, Idzko M, Zeitlinger M. Bergmann F, et al. Among authors: zeitlinger m. J Antimicrob Chemother. 2024 May 2;79(5):1169-1175. doi: 10.1093/jac/dkae088. J Antimicrob Chemother. 2024. PMID: 38546795
Immunogenicity and safety of COVID-19 booster vaccination: A population-based clinical trial to identify the best vaccination strategy.
Sieghart D, Hana CA, Dürrschmid C, Heinz LX, Haslacher H, Zlesak M, Piccini G, Manenti A, Montomoli E, Jorda A, Fedrizzi C, Hasenoehrl T, Zdravkovic A, Anderle K, Wiedermann U, Drapalik S, Steinbrecher H, Bergmann F, Firbas C, Jordakieva G, Wagner B, Leonardi M, Pierleoni G, Ballini M, Benincasa L, Marchi S, Trombetta C, Perkmann T, Crevenna R, Zeitlinger M, Bonelli M, Aletaha D, Radner H. Sieghart D, et al. Among authors: zeitlinger m. J Clin Virol. 2024 Feb 28;173:105661. doi: 10.1016/j.jcv.2024.105661. Online ahead of print. J Clin Virol. 2024. PMID: 38503118
277 results